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Finally, we aimed for a translational validation of our data in cartilage
samples from OA patients.
Methods: Human articular chondrocytes (hACs) stimulated or not with
LiCl were used to carefully map the presence or absence of DOT1L
protein complexes suggested earlier in leukemia cells, using a series of
speciﬁc immunoprecipitation experiments. To elucidate the transcrip-
tional network of Dot1l, we performed a microarray of hACs from 5
non-OA fracture patients treated with a speciﬁc DOT1L inhibitor
(EPZ5676) or vehicle control. The differentially expressed genes were
explored with the limma package. String-DB and Panther were used for
gene network analyses. Based on the microarray analysis, selected
genes were conﬁrmed by quantitative PCR. To establish the role of
DOT1L in the maintenance of hACs phenotype, hACs were cultured in
monolayer in the presence or absence of EPZ5676, and RNA and protein
were isolated at serial passages (P0 to P5). We analyzed by quantitative
PCR the gene expression of known genes important for chondrocyte
biology and/or genes that appeared in the microarray of DOT1L inhib-
ition. Activation of the Wnt canonical and non-canonical signaling
cascades was analyzed by Western blot. For translational validation we
analyzed the differential gene expression proﬁle of damaged as com-
pared to intact cartilage areas within the same joint of patients with hip
OA.
Results: The presence of different DOT1L elongation complexes was
conﬁrmed in hACs. The CoIP experiments revealed that DOT1L interacts
directly with ENL, AF10 and active beta-catenin (more strongly when
cells were treated with LiCl to stabilize beta-catenin) and with AF4 and
AF5 (only with cells were treated with LiCl). The formation of these
complexes was disrupted when DOT1L was inhibited. In the microarray,
1937 genes signiﬁcantly changed (p<0.05) in DOT1L inhibited samples
compared to vehicle treated samples (1048 genes were down-regu-
lated, 889 up-regulated). In EPZ5676 treated samples, chondrocyte
differentiation-associated genes, such as ACAN, RGS5, GDF10 and LOXL2
were down-regulated; OA-related genes, such as MMP1, CCL7, CCL8 and
GPNMB were up-regulated; and WNT target genes, ligands and antag-
onists such as LEF1, WNT5A and DKK1 were signiﬁcantly up-regulated.
In the de-differentiation experiment, in vitro expanded hACs showed
progressive changes in gene expression. Genes involved in relevant
pathways for cartilage biology such as the WNT, NOTCH and BMP
pathways exhibited signiﬁcant changes that were highly accentuated by
DOT1L inhibition. We successfully validated these targets of interest in
samples from patients with OA condition.
Conclusions: Our transcriptomic, protein and gene interaction
approach provides novel insights into the DOT1L molecular network
and its putative role in osteoarthritis and cartilage. These data further
support an important role for DOT1L in joint homeostasis as a key
regulator of WNT signaling and other growth factor cascades in the
joint.
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DISCRIMINATING BETWEEN PUTATIVE EPIGENETIC OSTEOARTHRITIS
DISEASE DRIVERS AND SHEER MARKERS
W. den Hollander, Y.F. Ramos, N. Bomer, S. Elzinga, R. van der Breggen,
N. Lakenberg, W.J. de Dijcker, E.H. Suchiman, B.J. Duijnisveld,
S. B€ohringer, J.J. Houwing-Duistermaat, E.P. Slagboom, S.D. Bos,
R.G. Nelissen, I. Meulenbelt. LUMC, Leiden, Netherlands
Purpose: It has become increasingly clear that DNA methylation is
eminently involved in osteoarthritis (OA) pathology, as reﬂected by the
large number of differentially methylated CpGs that have been reported
between healthy, preserved and lesioned articular cartilage. However,
as with the vast number of differentially expressed genes observed in
OA affected articular cartilage, it remains unclear whether these
observed differences are either cause or consequence of the disease. By
combining genome wide methylation, expression and single nucleotide
polymorphism (SNP) datasets we aim to achieve directional insight in
the observed epigenetic and transcriptional changes in OA affected
articular cartilage and report on putative protective and susceptibility
loci.
Methods: Transcriptional activity of CpGs (t-CpGs) was assessed using
genome wide gene expression and DNA methylation data of respec-
tively 33 and 31 pairs of preserved and lesioned articular cartilage.
Disease responsive t-CpGs were identiﬁed by means of differential
methylation between preserved and lesioned cartilage. Additionally, we
addressed proximal SNPs near the OA responsive t-CpGs. Statisticalanalyses were corrected for age, sex, joint and technical covariates,
while a random effect was included to correct for possible correlations
between paired samples.
Results: Of the 9838 transcribed genes in articular cartilage, 2324 cor-
related signiﬁcantly with the methylation status of 3748 t-CpGs , both
canonically negative (N¼1741) as positive (N¼2007) correlations were
observed. Hypomethylation and hypermethylation (FDR<0.05,
jDbj>0.05) were observed for 92 and 59 t-CpGs, respectively, covering
117 unique genes. Signiﬁcant enrichment for developmental and ECM
maintenance pathways was observed, indicating possible reactivation
of endochondral ossiﬁcation. Finally, we observed 11 and 84 OA carti-
lage relevant genes of which, respectively, methylation and expression
is additionally affected by genetic variation. Among others, we here
present the potential disease driving genes ROR2 and CAV1 (ﬁgure 1), as
reﬂected by differential expression between preserved and lesioned
cartilage and, moreover, epigenetic and genetic transcriptional
consequences.
Conclusions: We have shown that OA related epigenetic differences
need to be integrated with other sources of molecular data, such as
genomic and transcriptomic, to enhance our understanding of the
pathophysiological processes of OA. Furthermore, by integration of
multiple layers of genome wide data we have identiﬁed genes, such as
ROR2 and CAV1, which are likely functionally involved in OA patho-
physiology, as opposed to sheer consequence. Although targeting DNA
methylation seems unlikely to stand at the basis for developing treat-
ments, it serves to deepen our understanding of the complex tran-
scriptomic changes in OA affected articular cartilage. Finally, our results
comprise an important step in understanding the reported widespread
epigenetic changes occurring in OA affected articular cartilage.
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PROBING THE ARTICULAR CARTILAGE TRANSCRIPTOME FOR
GENETIC OSTEOARTHRITIS SUSCEPTIBLITY
W. den Hollander, I. Pulyakhina, N. Bomer, Y.F. Ramos,
R. van der Breggen, S. Bos, P-B. A. 't Hoen, E.P. Slagboom, R.G. Nelissen,
I. Meulenbelt. LUMC, Leiden, Netherlands
Purpose: Genome wide approaches have supplied the osteoarthritis
(OA) ﬁeld with robust susceptibility loci. A number of these risk alleles
act by affecting transcriptional regulation of genes in cis, particularly in
disease relevant tissues. For OA this has been demonstrated previously
for e.g. ALDH1A2, DIO2 and GDF5 by a marked allelic imbalance (AI) in
articular cartilage, a transcriptional phenomenon in which the two
alleles in heterozygous carriers are expressed to unequal extent. Here,
we set out to address the entire articular cartilage transcriptome by
means of RNA sequencing and have assessed AI in all cartilage
expressed genes.
Methods: From 21 patients (6 hips, 15 knees) preserved and lesioned
cartilage were collected. Additionally, from, respectively, 21 (14 hip, 7
knee) and 5 (2 hip, 3 knee) patients, we collected preserved or lesioned
cartilage only. RNA sequencing resulted in 10 million paired-end 100x2
bp long reads per sample. AI was performed on SNPs called using
SNVMix2 with minimum coverage of 25. To avoid rare genetic variants,
only SNPs that were observed in >9 samples were analysed. Fur-
thermore, non-dbSNP A>G SNPs were removed as potential RNA-edit-
ing events. Differential gene expression between preserved and paired
lesioned cartilage was performed using the edgeR package.
Results: We assessed AI in 15216 heterozygous coding SNPs of the
articular cartilage transcriptome and observed that 1175 SNPs tagged AI
of 493 unique genes (FDR<0.05, 0.1<minor/major allele ratio<0.4).
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ceptibility genes (e.g. ALDH1A2, DIO2, GDF5, ﬁgure 1), as well as a
substantial number of novel AI events in cartilage expressed genes (e.g.
PTGES3P1, CHST6, ITGA10, CD55, ﬁgure 1). Next, to gain disease relevant
insight in the direction of the observed AI, we addressed differential
gene expression between preserved and paired lesioned cartilage.
Among the 11955 aligned Ensembl identiﬁers that passed quality con-
trol, 549 and 158 were respectively signiﬁcantly (FDR<0.05) down
(mean FC<0.667) and up (mean FC>1.5) regulated in lesioned compared
to paired preserved cartilage. Among the total 707 genes that were
differentially expressed, 31 were subject to AI marked by 71 SNPs. As
proof of principle, we here present AI of the COMP gene, detected,
among others, in heterozygous carriers of rs4808155 (ﬁgure 1) which is
in full linkage disequilibrium (D’¼1) with rs8104411, a previously
reported OA susceptibility SNP (Ramos et al. 2014). Furthermore, COMP
was signiﬁcantly up regulated in lesioned cartilage (FDR<0.005,
FC>1.5).
Conclusions: By conﬁrming earlier reports and identifying new genes
likely involved in OA disease progression, we here demonstrate the
power of next generation RNA sequencing. In this respect, the 71
observed genetic variants that confer AI in the 31 genes that addition-
ally mark the OA disease process by differential gene expression, are
likely to be causally or protectively involved in the complex OA path-
ophysiology of articular cartilage, as they stress or attenuate the
observed differential expression of the respective genes. Although these
genetic variants do bear transcriptomic functionality in disease relevant
tissue, additional functional approaches in cell or animal models are
necessary to further characterize such causal relationships.
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DEMETHYLATION OF AN NUCLEAR FACTOR-KB (NF-KB) ENHANCER
ELEMENT ORCHESTRATES INOS INDUCTION IN OSTEOARTHRITIS
VIA CELL CYCLE REGULATION
M.C. de Andres y, A. Takahashi y,z, R.O. Oreffo y. yUniv. of Southampton.
Faculty of Med., Southampton, United Kingdom; z Tohoku Univ. Sch. of
Med., Sendai, Japan
Purpose: Osteoarthritis (OA) is a complex disease of the joint, charac-
terized by progressive degradation of the cartilage matrix by aggreca-
nases and collagenases. In normal adult cartilage, chondrocytes present,
in the non-stressed steady state, as quiescent cells demonstrating
negligible turnover of the cartilage matrix. In contrast, in OA, the
chondrocytes become “activated”, characterized by cell proliferation,
cluster formation, and the increased production of matrix proteins and
matrix-degrading enzymes. Nitric oxide, the product of inducible nitric
oxide synthase (iNOS), not only suppresses the synthesis of cartilage
matrix, but also increases expression of proteases in OA and we have
recently described that demethylation of the NF-kB enhancer region at
5.8 kb of the iNOS gene leads to increased transcription through
elevated binding of this transcription factor. The current study has
examined the methylation proﬁle of the NF-kB enhancer region at 5.8
kb of iNOS and the subsequent role in the induction of OA via cell cycle
regulation.
Methods: Human articular cartilage samples were obtained from 12
patients following hemiarthroplasty as a consequence of femoral neck
fracture (NOF) and from 16 OA patients who underwent total hip
arthroplasty. Isolated primary human chondrocyte samples (n ¼ 7)were cultured for 5 weeks in 2 groups: (i) cultured without treatment
(control culture) and (ii) cultured using 2 mM 5-azadeoxycytidine (5-
aza-dC). Percentage methylation was determined by pyrosequencing,
gene expression by qPCR and cell proliferation was determined using
the MTT assay. Transient transfections using the chondrocytic cell line
C28/I2 were induced to determine the effect of the NF-kB enhancer
region on cell proliferation and the inﬂuence of DNA methylation. Cell
cycle distribution was analysed by ﬂuorescence-activated sorting
(FACS).
Results: Analysis of several NF-kB enhancer elements localised
upstream of the 5.8 kb of the iNOS gene showed that this element is
crucial for induction of the human iNOS promoter in articular chon-
drocytes. In vitro de-methylation with 5-aza-dC showed decreased
levels of DNA methylation at CpG sites localised at 5.8 kb in articular
chondrocytes, which correlated with higher levels of iNOS expression.
In vitro methylation of the NF-kB enhancer region at 5.8 kb increased
the percentage of cells at G0/G1 cell cycle phase. Loss of methylation
within this region correlated with, enhanced proliferation and
increased number of cells at G2/M phase. OA chondrocytes demon-
strated upregulation of the G0/G1 cell cycle progression markers Cyclin
D1 and CDK6 in contrast to control cells.
Conclusions: We demonstrate the loss of methylation that occurs at
speciﬁc CpG sites localised at the 5.8 kb NF-kB enhancer region of the
iNOS gene in OA chondrocytes permits the binding of this transcription
factor activating the expression iNOS. This results in subsequent altered
cell cycle regulation of OA chondrocytes and altered proliferative phe-
notype and transmission of the pathogenic phenotype to daughter cells.
This study indicates that inhibition of cell cycle progression by iNOS
enhancer hypermethylation is capable of reducing pro-inﬂammatory
responses via down-regulation of NF-kB with important therapeutic
implications in OA.
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Purpose: Involvement of inﬂammation in the development and pro-
gression of OA has been implicated. Interleukin 8 (IL-8) is an inﬂam-
matory chemokine, involved in the inﬂammatory process and the
pathophysiology of OA. Importantly, within IL8, the 1000-bp of the
proximal promoter region contains only three CpG sites all located close
to transcriptional binding sites for NF-kB, AP-1 and C/EBP. However, the
methylation status of these CpG sites and subsequent involvement in
the regulation of IL8 regulation remains, to date, unknown. The current
study has examined whether the increased expression of IL8 in human
OA is a consequence of epigenetic regulation, speciﬁcally DNA
hypomethylation.
Methods: Human articular cartilage samples were obtained from 15
patients following hemiarthroplasty as a consequence of femoral neck
fracture (NOF) and from 15 OA patients who underwent total hip
arthroplasty. IL8 expression levels and the percentage CpG methylation
were quantiﬁed by qRT-PCR and pyrosequencing to compare OA
patients with non-OA controls. Isolated primary human chondrocyte
samples (n ¼ 7) were cultured for 5 weeks in 2 groups: (i) cultured
without treatment (control culture) and (ii) cultured using 2 mM 5-
azadeoxycytidine (5-aza-dC). The effect of CpG methylation on IL8
promoter activity was determined using a CpG-free vector; co-trans-
fections with expression vectors encoding NF-kB, AP-1 and C/EBP were
subsequently undertaken to analyse for IL8 promoter activity in
response to changes in methylation status. Furthermore, to determine
the CpG sites critical for IL8 promoter activity, we compared IL8 wild
type promoter construct activity against 6 vectors containing mutations
at different CpG sites.
Results: IL8 expression in OA patients was 37-fold higher than in NOF
patients. OA chondrocytes displayed a 22%, 26% and 15% statistically
signiﬁcant (P<0.01) reduction in methylation status at the -116, -106
and -31 CpG sites respectively. Multiple regression analysis revealed
that the degree of methylation of the CpG site located at 116-bp was
the strongest predictor of IL8 expression. In addition, advanced age and
OA were associated with higher IL8 expression. IL8 expression by
chondrocytes cultured using 5-aza-dC was observed to be 4.0-fold
higher than in control culture chondrocytes. Signiﬁcantly, the
